Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
euroPLX 90 LisboneuroPLX 90 Lisbon
Not Confirmed
Not Confirmed
02-03 March, 2026
Not Confirmed
Not Confirmed
14-17 February, 2026
Suppliers Night ExpoSuppliers Night Expo
Not Confirmed
Not Confirmed
16-17 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
euroPLX 90 LisboneuroPLX 90 Lisbon
Industry Trade Show
Not Confirmed
02-03 March, 2026
Industry Trade Show
Not Confirmed
14-17 February, 2026
Suppliers Night ExpoSuppliers Night Expo
Industry Trade Show
Not Confirmed
16-17 February, 2026
Digital content

12 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/12/3237138/0/en/Verrica-Pharmaceuticals-Appoints-Chris-Chapman-as-Chief-Commercial-Officer.html

09 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/09/3234465/0/en/Verrica-Pharmaceuticals-Announces-Launch-of-YCANTH-for-the-Treatment-of-Molluscum-Contagiosum-in-Japan-by-Partner-Torii-Pharmaceutical.html

07 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/07/3214452/0/en/Verrica-Pharmaceuticals-Announces-First-Patient-Dosed-in-Phase-3-Program-Evaluating-YCANTH-VP-102-for-the-Treatment-of-Common-Warts.html

24 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/24/3193428/0/en/Verrica-Pharmaceuticals-Announces-Private-Placement-Financing-of-50-Million-to-Retire-Debt-and-Extend-Cash-Runway.html

10 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/10/3184504/0/en/Verrica-Pharmaceuticals-Presents-New-Data-on-VP-315-from-its-Phase-2-Clinical-Trial-in-Basal-Cell-Carcinoma-at-the-40th-Society-for-Immunotherapy-of-Cancer-Annual-Meeting.html

20 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/20/3169756/0/en/Verrica-Pharmaceuticals-Receives-Positive-Feedback-from-the-European-Medicines-Agency-EMA-Supporting-a-Clear-Regulatory-Path-Forward-to-File-for-Approval-of-YCANTH-in-the-European-.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE